US Stock MarketDetailed Quotes
SEEL Seelos Therapeutics
- 0.9069
- -0.0531-5.53%
Close Jun 14 16:00 ET
- 0.9101
- +0.0032+0.35%
Post 19:52 ET
2.36MMarket Cap-26P/E (TTM)
0.9999High0.8814Low277.76KVolume0.9869Open0.9600Pre Close257.90KTurnover10.80%Turnover RatioLossP/E (Static)2.61MShares398.400052wk High-0.07P/B2.33MFloat Cap0.881452wk Low--Dividend TTM2.57MShs Float25380000.0000Historical High--Div YieldTTM12.34%Amplitude0.8810Historical Low0.9280Avg Price1Lot Size
Seelos Therapeutics Stock Forum
Sign in to post a comment
$Seelos Therapeutics(SEEL.US$ $Cybin(CYBN.US$ $Mind Medicine(MNMD.US$ FDA advisory panel fails to endorse psychedelic MDMA therapy for PTSD
A panel of advisors to the U.S. FDA declined to endorse Lykos Therapeutics' application to market to psychedelic drug MDMA, also known as ecstasy, as a treatment for post-traumatic stress disorder.
The Psychopharmacologic Drugs Advisory Committee held votes on twoquestions. The first dealt was the drug's efficacy in PTSD, while the second aske...
A panel of advisors to the U.S. FDA declined to endorse Lykos Therapeutics' application to market to psychedelic drug MDMA, also known as ecstasy, as a treatment for post-traumatic stress disorder.
The Psychopharmacologic Drugs Advisory Committee held votes on twoquestions. The first dealt was the drug's efficacy in PTSD, while the second aske...
5
13
$Seelos Therapeutics(SEEL.US$
NEWS
Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
NEWS
Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
$Seelos Therapeutics(SEEL.US$ Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations
3
$Seelos Therapeutics(SEEL.US$ 3 MINUTES AGO, 8:15 AM EDT
VIA PR NEWSWIRE
SEEL
SHARE
NEW YORK, March 19, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. a company focused on the development of therapies for central nervous system disorders and rare diseases, today provided an update on top-line data of the Phase 2/3 HEALEY ALS Platform trial. This study was performed in collaboration with The Sean M. Healey and AMG Center, which is viewed as an influential force in ALS research and in carin...
VIA PR NEWSWIRE
SEEL
SHARE
NEW YORK, March 19, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. a company focused on the development of therapies for central nervous system disorders and rare diseases, today provided an update on top-line data of the Phase 2/3 HEALEY ALS Platform trial. This study was performed in collaboration with The Sean M. Healey and AMG Center, which is viewed as an influential force in ALS research and in carin...
1
1
$Seelos Therapeutics(SEEL.US$ Seelos Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.![]()
$Seelos Therapeutics(SEEL.US$ Seelos Therapeutics Announces Receipt of Minutes from its End of Phase II Meeting with the United States Food and Drug Administration (FDA) Highlighting Modifications to the Primary and Secondary Endpoints of its Phase II Study of SLS-002
1 MINUTE AGO, 8:00 AM EST
Company plans to continue its previously announced potential partnership discussions and expects to proceed to Phase III with SLS-002 in Adults with Major Depressive Disorder (MDD) at Imminent Risk ...
1 MINUTE AGO, 8:00 AM EST
Company plans to continue its previously announced potential partnership discussions and expects to proceed to Phase III with SLS-002 in Adults with Major Depressive Disorder (MDD) at Imminent Risk ...
1
$Seelos Therapeutics(SEEL.US$ Seelos Therapeutics Filed U.S. Patent Application #20240009113 : Treatment Of Protein Aggregation Myopathic And Neurodegenerative Diseases By Parenteral Administration Of Trehalose![]()
3
$Seelos Therapeutics(SEEL.US$ Seelos Therapeutics, Inc. Releases Letter to its Stockholders! VERY INTERESTING READ! Its in the news tab in ticker![]()
2
3
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
JESSE JAMES8832 : this isnt even about $cybn ... this stock has had nothing but good news for the last 8 momths and doesnt reallyt budge it lol but some off brand news hits and it goes down lol wtf.. i still believe in this guy tho im stilll here
JESSE JAMES8832 : thanks for update tho brother
TrytosaveabitOP JESSE JAMES8832: I know it doesn’t! I added it only because im starting to see a pattern with schedule 1 drugs even for legit reasons being hammered by the government agencies! Grrrrr
TrytosaveabitOP JESSE JAMES8832: You’re welcome! Sry I didn’t mean to confuse. Guess I shoulda thought it through a bit more? Hehehe! BTW how’s the new gig? Mis not seeing you during the day
JESSE JAMES8832 : hey bro I wasn't coming at you just the way moomoo or whoever orientation the news towards this and it doesn't even pertain to this stock... the gig is goin ok so far.. wasted a whole day yesterday driving down to Mansfield p.a. for lowes to have screwed up the order..
View more comments...